Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity

[1]  Cheng Yu,et al.  Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects. , 2018, Journal of neurosurgery.

[2]  K. Patel,et al.  Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases , 2017, American journal of clinical oncology.

[3]  Betty Y. S. Kim,et al.  Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  S. Nguyen,et al.  Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases , 2017, Cureus.

[5]  J. Sheehan,et al.  The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. , 2017, Journal of neurosurgery.

[6]  James J. Evans,et al.  Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases. , 2016, International journal of radiation oncology, biology, physics.

[7]  A. Baschnagel,et al.  Predictors of Radiation Necrosis in Long-term Survivors of Stereotactic Radiosurgery for Brain Metastases , 2016 .

[8]  H. Kluger,et al.  Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases? , 2016, Journal of neurosurgery.

[9]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[10]  M. Postow,et al.  Irradiation and immunotherapy: From concept to the clinic , 2016, Cancer.

[11]  H. Kluger,et al.  Systemic Immunotherapy for the Treatment of Brain Metastases , 2016, Front. Oncol..

[12]  Y. Yamada,et al.  Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. , 2015, International journal of radiation oncology, biology, physics.

[13]  K. Margolin,et al.  Immune checkpoint blockade in patients with melanoma metastatic to the brain. , 2015, Seminars in oncology.

[14]  H. Ishwaran,et al.  Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.

[15]  K. Shirai,et al.  Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery , 2014, Cancer medicine.

[16]  Brady T. West,et al.  Ipilimumab and radiation therapy for melanoma brain metastases , 2013, Cancer medicine.

[17]  S. Demaria,et al.  An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer , 2013, Cancer Immunology Research.

[18]  J. Golfinos,et al.  Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery , 2013, Melanoma research.

[19]  D. Marcus,et al.  Outcome with stereotactic radiosurgery (SRS) and ipilimumab (Ipi) for malignant melanoma brain metastases. , 2013 .

[20]  Sacha Gnjatic,et al.  The abscopal effect associated with a systemic anti-melanoma immune response. , 2013, International journal of radiation oncology, biology, physics.

[21]  B. Neyns,et al.  Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies. , 2012, European journal of cancer.

[22]  E. Kasper,et al.  Melanoma brain metastasis: overview of current management and emerging targeted therapies , 2012, Expert review of neurotherapeutics.

[23]  J. Knisely,et al.  Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. , 2012, Journal of neurosurgery.

[24]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[25]  J. Wolchok,et al.  Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. , 2012, The Lancet. Oncology.

[26]  Jedd D. Wolchok,et al.  Immunologic correlates of the abscopal effect in a patient with melanoma. , 2012, The New England journal of medicine.

[27]  Axel Hoos,et al.  Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. , 2011, The New England journal of medicine.

[28]  B. Engelhardt,et al.  Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle , 2011, Fluids and Barriers of the CNS.

[29]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[30]  C. Hunter,et al.  Trafficking of immune cells in the central nervous system. , 2010, The Journal of clinical investigation.

[31]  C. Garbe,et al.  Determinants of survival in patients with brain metastases from cutaneous melanoma , 2010, British Journal of Cancer.

[32]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[33]  P. Brown,et al.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. , 2009, International journal of radiation oncology, biology, physics.

[34]  K. Shannon,et al.  Determinants of outcome in melanoma patients with cerebral metastases. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  L Souhami,et al.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. , 2000, International journal of radiation oncology, biology, physics.

[36]  J. Cairncross,et al.  Radation therapy for brain metastases , 1980 .

[37]  James J. Evans,et al.  Phase I Study of Ipilimumab Combined with Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients with Brain Metastases , 2018 .

[38]  R. Fietkau,et al.  Antitumor immune responses induced by ionizing irradiation and further immune stimulation , 2013, Cancer Immunology, Immunotherapy.